<DOC>
	<DOCNO>NCT00778778</DOCNO>
	<brief_summary>The objective study ass single-dose relative bioavailability Ranbaxy Bristol-Myers Squibb Company ( CEFZIL Â® ) 500 mg cefprozil tablet , fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Cefprozil Tablets , USP 500 mg Under Fasting Conditions</brief_title>
	<detailed_description>This blind , randomize , single dose , 3-way crossover comparative bioavailability study perform 27 healthy adult volunteer ( 13 male 14 female ) . In period , subject house least 10 hour dose 10 hour post dose event . Subjects receive single oral 500 mg cefprozil dose assign formulation , 240 mL water fast condition . Food restrict 10 hour dose 4 hour post dose water permit 2 hour dose restrict 2 hour follow dose allow ad libitum time . The dos separate washout period 14 day . A total twenty seven ( 27 ) healthy adult volunteer ( 13 male 14 female ) enrol study , twenty four ( 24 ) subject ( 11 male 13 female ) complete clinical phase study .</detailed_description>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Cefprozil</mesh_term>
	<criteria>Subject candidate fulfil follow inclusion criterion eligible participation study , unless otherwise specify . 1 . Healthy adult male female volunteer , 18 55 year age ; 2 . Weighing least 52 kg male 45 kg female within 15 % ideal weight ( Table `` Desirable Weights Adults '' , Metropolitan Life Insurance Company , 1983 ) ; 3 . Medically healthy subject clinically normal laboratory profile , vital sign ECGs . 4 . Females childbearing potential either sexually inactive ( abstinent ) 14 day prior first dose throughout study use one follow acceptable birth control method : surgically sterile ( bilateral tubal ligation , hysterectomy , bilateral oophorectomy ) 6 month minimum ; IUD place least 3 month ; Barrier method ( condom , diaphragm ) spermicide least 14 day prior first dose throughout study ; Surgical sterilization partner ( vasectomy 6 month minimum ) ; Hormonal contraceptive least 3 month prior first dose study Other birth control method may deem acceptable e ) Postmenopausal woman amenorrhea least 2 year eligible f ) Voluntarily consent participate study Subjects exclude study evidence follow screening time study : 1 . History presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease . 2 . In addition , history presence : alcoholism drug abuse within past year ; hypersensitivity idiosyncratic reaction cefprozil , cephalosporin antibiotic , penicillin ; Female subject pregnant lactating . c ) Positive result HIV , HbsAg and/ HCV test . ) Subjects special diet ( whatever reason ) 28 day prior first dose throughout study e ) Subjects completion study , would donate excess : 500 mL blood 14 day , 1500 mL blood 180 day , 2500 mL blood 1 year . f ) Subjects participate another clinical trial within 28 day prior first dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence cefprozil 500mg tablet fasting condition</keyword>
</DOC>